Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Winter 2019 - Integrated Care
Download Issue
Share
Up Front
Publisher's Corner
Keeping Pace with the Changing Healthcare Landscape
By Patrick M. Schmidt
Features
The Many Faces of Parvovirus B19: IVIG to the Rescue?
By
E. Richard Stiehm, MD
The Growing Threat of Antibiotic-Resistant Illnesses
By
Diane L.M. Cook
Combating the Shortage of Primary and Specialty Care Physicians
By
Meredith Whitmore
Myths and Facts: Autoimmune Disorders
By
Ronale Tucker Rhodes, MS
BioTrends Watch
Washington Report
Grants Awarded to Fund New Clinical Trials for Products to Treat Rare Diseases
Revised Medical Program Integrity Manual Is a 'Roadmap' to LCD Process
Court Upholds Reimbursement Cut for 340B Drug Discount Program
CMS Final Rule Updates 2019 Medicare Payment Rates and Wage Index for Hospices
CMS Launches Medicare Advantage Qualifying Payment Arrangement Incentive Demonstration
Reimbursement FAQs
Impacts of the Opioid Crisis Response Act
Healthcare Management
Preventing and Responding to Cyber Attacks
Industry News
New Hemophilia A Treatment Approved by FDA
Cervical Cancer Vaccines Safe and Effective in Girls and Women
Single-Dose Flu Drug Given Priority Review by FDA
Cinryze Approved for Preventing Pediatric Angioedema Attacks
Second JAK Inhibitor Drug for RA Approved by FDA
FDA Approves Marijuana-Based Drug for Seizures
FDA Approves Diagnostic Test for Lupus and ANCA-Associated Vasculitis
Rituxan Approved to Treat Severe Pemphigus Vulgaris
FDA Approves Fast-Acting, Single-Dose Flu Medication
First EpiPen Generics Get FDA Approval
Study Shows Newborns' Immune Systems Ramp Up After Birth
FDA Approves HPV Vaccine for 27- to 45-Year-Old Men and Women
BioFocus
Industry Insight
Grifols' AMBAR Study Findings: Albumin Plasma Exchange May Reduce Progression of Moderate Alzheimer's Disease
By Keith Berman, MPH, MBA
Patient Profile
Treating Neuropathy with IVIG: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Treating Neuropathy with IVIG: A Physician's Perspective
By Trudie Mitschang
Disease Profile
Heads-Up on Keystone Virus Disease
By Jim Trageser
BioSources
BioResearch
Neonatal Fc Receptor Antagonist Efgartigimod Sustainably Reduces Circulating IgG Level in Humans
Improved Social and Behavioral Scores Following IVIG Therapy Suggest a Neuroimmune Etiology in Some Children with Autism